The weekly litigation news digest is live. Subscribe now

IP Verse

Animal Models And Therapeutic Molecules - EP3028564

The patent EP3028564 was granted to Kymab on Jan 24, 2024. The application was filed on Jul 7, 2010 under application number EP16151214A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3028564

KYMAB
Application Number
EP16151214A
Filing Date
Jul 7, 2010
Status
Patent Maintained As Amended
Dec 22, 2023
Publication Date
Jan 24, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
REGENERON PHARMACEUTICALSJun 26, 2018J A KEMPWITHDRAWN

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP3028565
OPPOSITIONUS2012204278
OPPOSITIONUS7205148
OPPOSITIONWO02066630
OPPOSITIONWO2007117410
OPPOSITIONWO2009013620
OPPOSITIONWO2009076464
SEARCHUS2006015957
SEARCHUS2009083870
SEARCHWO02066630
SEARCHWO2006122442
SEARCHWO2007117410
SEARCHWO2009013620
SEARCHWO2009076464

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents